- US12194138utility2025Devices and Methods for Delivering Therapeutics0 cites
- US12195453utility2025Antiproliferation Compounds and Uses Thereof0 cites
- US12186306utility2025Methods of Treatment for Cystic Fibrosis0 cites
- US12187698utility2025Crystalline Forms of C 21 H 22 Cl 2 N 4 O 20 cites
- US12187731utility2025Compounds Useful as Inhibitors of ATR Kinase0 cites
- US12173324utility2024Differentiation of Pancreatic Endocrine Cells0 cites
- US12173337utility2024Nucleic Acid Encoding Modified Membrane Type Serine Protease 1 (MTSP-1) Polypeptides and Methods of Use0 cites
- US12168009utility2024Modulators of Cystic Fibrosis Transmembrane Conductance Regulator0 cites
- US12161674utility2024CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses Thereof0 cites
- US12134767utility2024Materials and Methods for Treatment of Hemoglobinopathies0 cites
- US12129471utility2024Materials and Methods for Treatment of Human Genetic Diseases Including Hemoglobinopathies0 cites
- US12121524utility2024DNA-PK Inhibitors0 cites
- US12122788utility2024Process of Making CFTR Modulators0 cites
- US12116343utility2024Inhibitors of APOL1 and Methods of Using Same0 cites
- US12116606utility2024Complement Factor I-related Compositions and Methods0 cites
- US12084438utility2024GCN2 Inhibitors and Uses Thereof0 cites
- US12060346utility2024Inhibitors of APOL1 and Methods of Using Same0 cites
- US12053531utility2024Materials and Methods for Treatment of Duchenne Muscular Dystrophy0 cites
- US12049645utility2024Differentiation of Pancreatic Endocrine Cells0 cites